TrialClinical and experimental immunology2024

Valganciclovir modulates the tumor necrosis factor axis molecules expression and CD4+ T-cell subsets in disseminated Kaposi Sarcoma patients.

Lucero A Ramon-Luing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.